Yes, but generally speaking what I'm really saying is: Technologies like the one in question, that can increase the life quality of a large part of the population have a better chance of being developed by minor companies, group of individuals (as in this case) or outsiders (Google, Apple, etc.) rather than a Pharmaceutical company that has an already well established product in the market with a positive revenue stream.